xylazine has been researched along with Cardiac Toxicity in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Polegato, BF | 1 |
| Minicucci, MF | 1 |
| Azevedo, PS | 1 |
| Carvalho, RF | 1 |
| Chiuso-Minicucci, F | 1 |
| Pereira, EJ | 1 |
| Paiva, SA | 1 |
| Zornoff, LA | 1 |
| Okoshi, MP | 1 |
| Matsubara, BB | 1 |
| Matsubara, LS | 1 |
1 other study available for xylazine and Cardiac Toxicity
| Article | Year |
|---|---|
Acute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in rats.
Topics: Animals; Blood Pressure; Cardiotoxicity; Doxorubicin; Echocardiography; Heart; Intercellular Adhesio | 2015 |